Jamilla Goedegebuur and Colleagues on VTE Management in Case of PAD
RPTH Journal shared on LinkedIn:
”How to manage VTE in patients with peripheral arterial disease
Patients with peripheral arterial disease routinely receive antithrombotic therapy, yet the optimal management of a VTE in this population remains uncertain.
Using nationwide Dutch data , this study highlights substantial variability in real-world practice and underscores the need for clear guidance and consensus in this complex clinical scenario.
Read the full article here.”
Article: Antithrombotic therapy in lower extremity peripheral artery disease patients with venous thromboembolism: a nationwide cohort study
Authors: Jamilla Goedegebuur, Elena Butera, Qingui Chen, Behnood Bikdeli, Walter Ageno, Roberto Pola, Angelo Porfidia, Stefano Barco, Thijs E. van Mens, Joost R. van der Vorst, Suzanne C. Cannegieter, Frederik
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 23, 2026, 15:58Mel Snyder: Beyond Sickle Cell Disease to the Future of Pediatric Genetics
-
Jul 23, 2026, 15:43Lorna Knight: The Next Frontier in Sickle Cell Disease Is Access
-
Jul 23, 2026, 15:29Ben Kleinstiver: Overcoming a Major Barrier to Scalable Gene Editing
-
Jul 23, 2026, 15:28Modernizing DIC Diagnosis in Cirrhosis: Building an International Registry for Precision Hemostasi
-
Jul 23, 2026, 14:32Saneha Anjum Shaikh: Why Antibody Screening Must Be Standard Practice in Modern Blood Banking
-
Jul 23, 2026, 14:00Ron Vezina: Canadian Blood Services Issues Urgent Donation Appeal
-
Jul 23, 2026, 13:46Sebastian Szmit: Understanding Troponins in Modern Cardio-Oncology
-
Jul 23, 2026, 13:41Colleen Grady: Why Normal Hemoglobin Does Not Exclude Iron Deficiency
-
Jul 23, 2026, 13:22Jacob Kelly: AHA Review Highlights Coffee’s Cardiovascular Benefits